New treatment strategy for epilepsy

Researchers found out that the conformational defect in a specific protein causes autosomal dominant lateral temporal lobe epilepsy which is a form of familial epilepsy. They showed that treatment with chemical corrector called 'chemical chaperone' ameliorates increased seizure susceptibility in a mouse model of human epilepsy by correcting the conformational defect.